Press Releases

With this acquisition of renowned producer of hard capsules and pharmaceutical processing equipment for oral dosage, Roquette aims at reinforcing its global position in the pharmaceutical industry.

Part of its Asia Pacific Innovation Center, this new dedicated facility allows customers to experience Roquette offerings through Asian culinary and sensory experiences, from early innovation to the final plate.

With an investment of 4.5 million euros, the new Center is a key part of the company’s Research and Development global network.

Roquette Announces Strategic Investment and Innovation Agreement with Beren Therapeutics P.B.C.

Roquette Spotlights Stability in Probiotic Supplements with Launch of New Excipient PEARLITOL® ProTec Co-Processed Mannitol-Starch at Vitafoods Europe 2023

Roquette celebrates the grand opening of its new Pharmaceutical Innovation Center, located near Philadelphia, Pennsylvania, right in the heart of the United States’ Northeastern pharmaceutical corridor.

This partnership aims to design brand new nutrition and health ingredients targeting an optimal interaction with gut microbiota to contribute to a healthy diet.

Roquette, Agri Obtentions, Eurial, Greencell, INRAE and the Université Lumière Lyon 2, have announced the launch of an ambitious collaborative project: AlinOVeg "Innovating in plant-based food".

This partnership is one more step towards Roquette’s vision of tastier and healthier plant-based ingredients that respond to global consumers’ expectations.

CPHI Frankfurt 2022: New PEARLITOL® CR-H mannitol and PEARLITOL® 200 GT mannitol are unveiled. Join the Roquette team on stand 80C90 (Excipient Gold area) to discover the latest innovations in direct compression technology, designed to overcome unique drug formulation challenges and support expansion into novel application areas.

This new line of organic pea ingredients reinforces its leadership position in the food revolution.

Roquette today announces its complete acquisition of India-based excipient manufacturer, Crest Cellulose.

Developed specifically for active pharmaceutical ingredients (APIs) that are highly sensitive to reducing sugars, PEARLITOL® 150 SD supports opportunities to unlock advanced tablet dosage forms – even when using challenging active ingredients. 

The company extends its NUTRALYS® plant protein range to better address consumer demand for healthier food.

This launch enhances Roquette’s strong position on the overall protein market as a key leader for plant-based solutions and supports the company’s effort to be the best partner for customers wishing to develop new and delicious plant-based foods.